The unique features of the Vi-Syringe™ allow a user to adjust an outer dosage indicator to specific dosage measurements through tactile and audible features. The syringe offers a locking mechanism to allow a dosage to be locked in place for storage.
The Vi-Syringe™ is also designed with a needle guard coupler and guide that protects against needle sticks during the vial withdrawal and provides a method to position the needle for injection.
For diabetic patients, vision impairment typically occurs as a result of Diabetic Retinopathy (DR). DR is a progressive disease with patients gradually losing vision over a period of time, oftentimes resulting in total blindness. The Vi-Syringe™ is designed to offer individualized solutions for patients diagnosed with all stages of DR. The Vi-Syringe™ is comprised of enlarged raised numeric indicia for patients suffering from mild DR and offers braille and audible cues for those patients who are blind.
- *not available in all territories
- *The Vi-Syringe™ is a trademark of Asepsis Medical Technologies, LLC., and covered by one or more Patents Pending.